IMV Inc.’s $25 Million Public Offering

McCarthy Tétrault advised IMV in connection with the offering.

On July 20, 2021, IMV Inc. closed an underwritten public offering of 14,285,714 units, for total gross proceeds of US$25 million. IMV intends to use the net proceeds of the offering to further several of its clinical developments and for general corporate purposes.

IMV is a biopharmaceutical company based in Dartmouth, Nova Scotia. It is focused on creating more effective immunotherapies for cancer and other diseases.

The McCarthy Tétrault team was led by Philippe Leclerc (Picture) and included Myreille Gilbert and Mireille Trottier (Securities), and Marie-Soleil Landry and Geneviève Favreau (Tax).

 

Involved fees earner: Geneviève Favreau – McCarthy Tétrault; Myreille Gilbert – McCarthy Tétrault; Marie-Soleil Landry – McCarthy Tétrault; Philippe Leclerc – McCarthy Tétrault; Mireille Trottier – McCarthy Tétrault;

Law Firms: McCarthy Tétrault;

Clients: IMV Inc.;

Author: Martina Bellini